Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system, causing inflammation and damage to myelin, the protective layer of nerve fibers. Mesenchymal stem cells (MSCs) have shown promise in treating MS due to their immunomodulatory and neuroregenerative properties. MSCs can reduce inflammation and promote the repair of damaged tissues, thereby improving symptoms and quality of life for patients.

Multiple system atrophy is a neurodegenerative disease that combines symptoms of parkinsonism, cerebellar dysfunction, and autonomic dysfunction. Clinical trials have investigated the use of MSCs administered intrathecally (directly into the cerebrospinal fluid) to treat MSA. Preliminary results suggest that MSCs may slow the progression of the disease and improve some of its symptoms.

Traumatic brain injuries can result from blows or impacts to the head that disrupt normal brain function. MSCs have shown potential in improving recovery after a TBI due to their ability to modulate the immune response and promote tissue repair. Studies have demonstrated that MSCs can reduce inflammation, protect nerve cells, and enhance cognitive and motor function in patients with TBI.

Cardiovascular diseases are one of the leading causes of death worldwide. MSCs offer an innovative therapeutic approach for these conditions due to their ability to differentiate into cardiac cells, reduce inflammation, and promote the formation of new blood vessels (angiogenesis). Clinical trials have shown that MSCs can improve cardiac function and reduce tissue damage in patients with myocardial infarction and other heart diseases.

The gut microbiome plays a crucial role in overall body health. An imbalanced microbiome can contribute to inflammation and deterioration of the gut barrier. MSCs can help restore the balance of the gut microbiome by regulating immune cell activity and improving gut barrier function. This can be particularly beneficial for individuals with autism, as many patients experience gastrointestinal issues and microbiome imbalances.

MeRT (Modulation of Electromagnetic Resonance Therapy) is a non-invasive treatment based on repetitive transcranial magnetic stimulation (rTMS) aimed at optimizing brain functionality in patients with autism. MeRT therapy is personalized according to each patient’s individual brain activity, using advanced technologies to map and direct magnetic impulses to specific areas of the brain. This can enhance neural connectivity and, consequently, improve communication and behavioral skills.

The immune system plays a critical role in autism, with many theories suggesting that inflammation and abnormal immune responses may contribute to the disorder’s symptoms. MSCs have powerful immunomodulatory properties that can help regulate the immune system, reduce inflammation, and promote a more balanced environment in the body. This approach can significantly improve autism symptoms, offering a better quality of life for patients and their families.